Philips to buy BioTelemetry for $2.8 billion
Philips to buy BioTelemetry for $2.8 billion
Royal Philips on Friday announced plans to purchase a remote cardiac diagnostics and monitoring company for an estimated $2.8 billion. The transaction, under which Philips plans to acquire Malvern, Pa.-based company BioTelemetry for $72 per share in cash, is expected to close in the first quarter of 2021. BioTelemetry sells wearable heart monitors and analytics services that detect abnormal heart…
View On WordPress















